Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
公司代码MMSI
公司名称Merit Medical Systems Inc
上市日期Oct 22, 2090
CEOAronson (Martha Goldberg)
员工数量7400
证券类型Ordinary Share
年结日Oct 22
公司地址1600 West Merit Park Way
城市SOUTH JORDAN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编84095
电话18012531600
网址https://www.merit.com/
公司代码MMSI
上市日期Oct 22, 2090
CEOAronson (Martha Goldberg)